|
AstraZeneca, Nektar constipation drug wins European approval
Send a link to a friend
[December 09, 2014] LONDON
(Reuters) - AstraZeneca's new drug for the treatment of opioid-induced
constipation, which was developed with Nektar Therapeutics, has been
approved in the European Union, the British company said on Tuesday.
|
|
 The approval for Moventig had been expected after the European
Medicines Agency gave a green light for the product in September.
The drug was also approved in September in the United States under
the brand name Movantik.
(Reporting by Ben Hirschler; Editing by Greg Mahlich)
[to top of second column] |
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
